Selena Z Kuo1, Marta Haftek1, Jennifer C Lai2. 1. Division of Gastroenterology/Hepatology, Department of Medicine, University of California, San Francisco, 513 Parnassus Ave, Med Sci, San Francisco, CA, 94143, USA. 2. Division of Gastroenterology/Hepatology, Department of Medicine, University of California, San Francisco, 513 Parnassus Ave, Med Sci, San Francisco, CA, 94143, USA. Jennifer.lai@ucsf.edu.
Abstract
BACKGROUND: Low medication adherence is known to contribute to worse health outcomes in the general population. AIM: We aimed to evaluate the medication regimen and determine the adherence levels among patients with end-stage liver disease. METHODS: We measured adherence in patients awaiting liver transplantation at a single center using the 8-item Morisky Medication Adherence Scale (MMAS-8), with a score <8 classified as low adherence. Medication regimen complexity was assessed using the Medication Regimen Complexity Index (MRCI) tool. Factors associated with low adherence were identified by logistic regression. RESULTS: Of 181 patients, 33% were female, median age was 62, and model for end-stage liver disease (MELD) score was 13. The median (IQR) number of medications was 10 (7-13), and the MRCI was 19 (13-27). In total, 54 (30%) were high adherers, and 127 (70%) were low adherers. In total, 42% reported sometimes forgetting to take their medication and 22% reported intermittent adherence within the past 2 weeks. The most common reasons for low adherence were: forgetfulness (27%) and side effects (14%). Compared to high adherence, low adherence was associated with higher number of medications, medication complexity, and diabetes, but lower rates of hepatocellular carcinoma and self-perceived health. In univariable logistic regression, total medication number (OR 1.08), MRCI (OR 1.04), diabetes (OR 2.38), HCC (OR 0.38), and lower self-perceived health (OR 1.37), were statistically significant factors associated with non-adherence. In multivariate analysis, only medication number without supplements (OR 1.14) remained significantly associated with medication non-adherence. CONCLUSION: A majority of patients awaiting liver transplantation demonstrated low medication adherence. Total number of medications and regimen complexity were strong correlates of low adherence. Our data underscores the need for chronic liver disease management programs to improve medication adherence in this vulnerable population.
BACKGROUND: Low medication adherence is known to contribute to worse health outcomes in the general population. AIM: We aimed to evaluate the medication regimen and determine the adherence levels among patients with end-stage liver disease. METHODS: We measured adherence in patients awaiting liver transplantation at a single center using the 8-item Morisky Medication Adherence Scale (MMAS-8), with a score <8 classified as low adherence. Medication regimen complexity was assessed using the Medication Regimen Complexity Index (MRCI) tool. Factors associated with low adherence were identified by logistic regression. RESULTS: Of 181 patients, 33% were female, median age was 62, and model for end-stage liver disease (MELD) score was 13. The median (IQR) number of medications was 10 (7-13), and the MRCI was 19 (13-27). In total, 54 (30%) were high adherers, and 127 (70%) were low adherers. In total, 42% reported sometimes forgetting to take their medication and 22% reported intermittent adherence within the past 2 weeks. The most common reasons for low adherence were: forgetfulness (27%) and side effects (14%). Compared to high adherence, low adherence was associated with higher number of medications, medication complexity, and diabetes, but lower rates of hepatocellular carcinoma and self-perceived health. In univariable logistic regression, total medication number (OR 1.08), MRCI (OR 1.04), diabetes (OR 2.38), HCC (OR 0.38), and lower self-perceived health (OR 1.37), were statistically significant factors associated with non-adherence. In multivariate analysis, only medication number without supplements (OR 1.14) remained significantly associated with medication non-adherence. CONCLUSION: A majority of patients awaiting liver transplantation demonstrated low medication adherence. Total number of medications and regimen complexity were strong correlates of low adherence. Our data underscores the need for chronic liver disease management programs to improve medication adherence in this vulnerable population.
Authors: Marina Serper; Rachel E Patzer; Peter P Reese; Kamila Przytula; Rachel Koval; Daniela P Ladner; Josh Levitsky; Michael M Abecassis; Michael S Wolf Journal: Liver Transpl Date: 2015-01 Impact factor: 5.799
Authors: Waleed M Sweileh; Manal S Ihbesheh; Ikhlas S Jarar; Adham S Abu Taha; Ansam F Sawalha; Sa'ed H Zyoud; Raniah M Jamous; Donald E Morisky Journal: Epilepsy Behav Date: 2011-05-14 Impact factor: 2.937
Authors: Marie Krousel-Wood; Tareq Islam; Larry S Webber; Richard N Re; Donald E Morisky; Paul Muntner Journal: Am J Manag Care Date: 2009-01 Impact factor: 2.229
Authors: Rachel E Patzer; Marina Serper; Peter P Reese; Kamila Przytula; Rachel Koval; Daniela P Ladner; Josh M Levitsky; Michael M Abecassis; Michael S Wolf Journal: Clin Transplant Date: 2016-08-29 Impact factor: 2.863
Authors: Kai Sun; Jackie Szymonifka; Henghe Tian; Yaju Chang; Jennifer C Leng; Lisa A Mandl Journal: Arthritis Care Res (Hoboken) Date: 2020-10 Impact factor: 4.794
Authors: Janet K Sluggett; Choon Ean Ooi; Stephanie Gibson; Manya T Angley; Megan Corlis; Michelle E Hogan; Tessa Caporale; Georgina A Hughes; Jan Van Emden; J Simon Bell Journal: Clin Interv Aging Date: 2020-06-02 Impact factor: 4.458
Authors: Kelly L Hayward; Patricia C Valery; W Neil Cottrell; Katharine M Irvine; Jennifer H Martin; Elizabeth E Powell Journal: Hepatol Commun Date: 2019-07-10